Information updates

ASCIA 2022 Conference Report

The ASCIA 2022 Conference was a highly successful hybrid event which was held from Tuesday 30th August to Friday 2nd September, with in-person participation in Melbourne.

The conference attracted more than 600 registered delegates, with around 60 per cent of delegates attending in person, and more than 150 sponsors and exhibitors. Delegates seemed to welcome their interactions with colleagues for the first time since 2019 at an ASCIA Conference.

Congratulations and thank you to the ASCIA 2022 Chair, Dr Dean Tey and the organising committee for compiling an outstanding program which included more than 40 sessions presented over four days.

ASCIA conferences are the leading source of allergy and clinical immunology CPD for health professionals in Australia and New Zealand. To provide further CPD opportunities, registered delegates can view sessions on demand for six months after the conference.

Read the full ASCIA 2022 Conference Report at

The Basten Oration presented by Dr David Hill can be viewed open access at

This news item was issued on 9 September 2022 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand.   

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia